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lsevier1. Introduction
Brewing public health crisis has been obsessed by two key fac-
tors, the emergence of antibacterial resistance in imperative
pathogenic species and a downturn in the ﬁgure of new anti-
bacterial agents coming through pharmaceutical company
pipelines (News and Analysis, 2010), with only six new antibi-
otics approved since 2003 (Fox, 2006). Consistent with histor-
ical data, the preponderance of antibiotics under clinical
development are natural products or derivatives thereof
(Donadio et al., 2010). However, WHO and many experts rec-
ommend policies encouraging the research and development of
new, cost effective and innovative drugs (WHO, 2005).
s-Triazine analogues have been already gained substantial
attention due to their cost effectiveness and diverse
36 P. Gahtori et al.antimicrobial activities such as antimalarial (Manohar et al.,
2010; Kumar et al., 2010), antibacterial (Nishigaki et al.,
1969; Zhou et al., 2006; Srinivas et al., 2006), antitumor
(Saczewski and Bulakowska, 2006; Matsuno et al., 2010), anti-
tubercular (Sunduru et al., 2010) etc. Previously we have
reported several triazine derivatives bearing pendent thiazole
motif showing considerable antibacterial activity by the virtue
of the presence of different lipophillic and electron withdrawing
groups (Singh et al., 2010; Gahtori et al., 2009, 2010). Further,
we have recognized a lead fragment pertaining to structural
feature necessary for hybrid thiazole-s-triazine to act as potent
antibacterials. On the basis of these results and as a part of our
endeavor on novel s-triazine antibacterial agents, we decided to
focus our attention around our identiﬁed lead and disclose
synthesis, SAR and antibacterial activities of newer hybrid
thiazole-s-triazine antibacterials, by assimilation of various
pharmacophoric groups.
2. Chemistry
Two novel series of hybrid chloro (Series A) and dichloro (Ser-
ies B) phenylthiazolyl-s-triazine derivatives were synthesized to
comprehend the role of electron withdrawing viz. chloro and
di-chloro substitution on phenylthiazolyl-s-triazine as well as
the inﬂuence of amino (–NH–) and mercapto (–S–) linker
bridge between phenylthiazole and s-triazine, towards antibac-
terial activity. Synthetic methods adopted for making com-
pounds are illustrated in Scheme 1. Synthesis of targeted
compounds was performed by means of nucleophilic displace-
ment of third chlorine atom of di-substituted-1,3,5-triazine in
the presence of NaHCO3 in dioxane under nitrogen atmo-
sphere to furnish clubbed chloro and di-chloro phenylthiazol-
yl-s-triazine derivatives (Fig. 1).N
N N
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Scheme 1 Reagents and condition: (a) KHCO3, aq Dioxane
phenylthiazolyl NaHCO3, aq dioxane 45–50 C (c) NaHCO3, dioxane3. Antibacterial efﬁcacy
All the targeted compounds (1a–9a) and (10b–18b) were
screened for their minimum inhibitory concentration (MIC)
against three selected gram-positive organisms viz. Lactoba-
cillus casei (NCIM-2651); Bacillus cereus (NCIM-2458);
Staphylococcus aureus (NCIM-2120) and three gram negative
viz Salmonella typhimurium (NCIM-2501); Escherichia coli
(NCIM-2065); Klebsiella aerogenes (NCIM-2098) by the
broth dilution method as recommended by the EUCAST
2000 procedure (EUCAST, 2000), with minor modiﬁcations
using Streptomycin and Penicillin as standard antibacterial
agents. Solutions of the tested compounds and reference
drugs were dissolved in dimethylsulfoxide (DMSO) at pre-
pared concentrations of 100, 50, 25, 12.5, 6.25, 3.125 lg/
ml. The chemical compound-broth medium in serial test
tube dilution was inoculated with equal amount of each bac-
terium and was incubated on a rotary shaker at 37 C for
24 h at 150 rpm. The incubation chamber was kept humid
and at the end of the incubation period, MIC values were
recorded as the lowest concentration of the substance that
gave no visible turbidity, i.e., no growth of inoculated
bacteria. In an effort to order the scope of antibacterial
activity in detail, a computational study of all titled com-
pounds was performed by using Molinspiration online
property calculation toolkit (http://www.molinspiration.
com/cgi-bin/properties).
4. Results and discussion
Two series of chloro (A) and dichloro (B) phenylthiazolyl-s-tri-
azine derivatives were synthesized and found in agreement
with spectroscopic analysis, e.g., IR spectra of all the productsS
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Figure 1 Chloro (1a–9a) and dichloro (10b–18b) phenylthiazolyl-s-triazine derivatives.
Table 1 Structural modiﬁcation and MIC of mono-chloro phenylthiazolyl-s-triazine derivatives (Series A).
Compounds X MIC (lg/ml)
Gram positive Gram negative
Lactobacillus
casei
(NCIM-2651)
Bacillus
cereus
(NCIM-2458)
Staphylococcus aureus
(NCIM-2120)
Salmonella typhimurium
(NCIM-2501)
Escherichia coli
(NCIM-2065)
Klebsiella
aerogenes
(NCIM-2098)
1a Cl >200 100 50 >200 100 100
2a HN 50 50 25 50 100 100
3a HN 25 50 25 25 25 50
4a
HN
3.125 6.25 3.125 6.25 12.5 50
5a
HN O
25 25 12.5 50 50 100
6a HS 50 50 25 50 100 100
7a HS 25 25 12.5 25 25 50
8a
HS
3.125 6.25 3.125 6.25 6.25 50
9a
HS O
25 50 25 50 25 50
Penicillin 1.562 1.562 3.125 12.5 12.5 12.5
Streptomycin 12.5 6.25 6.25 1.562 3.125 1.562
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Table 2 Structural modiﬁcation and MIC of di-chloro phenylthiazolyl-s-triazine derivatives (Series B).
Compounds X MIC (lg/ml)
Gram positive Gram negative
Lactobacillus
casei
(NCIM-2651)
Bacillus
cereus
(NCIM-2458)
Staphylococcus
aureus
(NCIM-2120)
Salmonella
typhimurium
(NCIM-2501)
Escherichia coli
(NCIM-2065)
Klebsiella
aerogenes
(NCIM-2098)
10b Cl 100 50 50 >200 100 100
11b HN 25 25 12.5 50 25 100
12b HN 12.5 25 12.5 25 50 100
13b
HN
3.125 3.125 6.25 6.25 6.25 50
14b
HN O
12.5 25 12.5 50 25 100
15b HS 50 100 25 100 50 200
16b HS 12.5 25 12.5 50 50 200
17b
HS
3.125 3.125 6.25 6.25 12.5 25
18b
HS O
25 25 25 50 50 100
Penicillin 1.562 1.562 3.125 12.5 12.5 12.5
Streptomycin 12.5 6.25 6.25 1.562 3.125 1.562
38 P. Gahtori et al.1a–9a and 10b–18b nearer at 3450 and 3350 cm1 attributable
to bonded primary amino groups is observed, where as second-
ary –NH linker between thiazole and s-triazine appears in the
region 3320–3140 cm1. Many strong absorption bands at
850–670 cm1 conﬁrm the existence of aromatic ring. Stronger
band at 920, 995 cm1 and medium band at 1650 cm1 are
indicative of vinyl groups. The 1H NMR spectrums reveal a
signal corresponding to the NH2 group at 4.12–4.48 ppm. Fur-
ther, these compounds are subsequently subjected to their
in vitro antibacterial efﬁcacy in terms of minimum inhibitory
concentration, MIC (Tables 1 and 2). The preliminary SAR
screening of these series indicates that many compounds exhib-
ited signiﬁcant to almost no activity against tested microorgan-
isms, among them compounds 4a, 8a, 13b and 17b displayed
interesting activities for some Gram positive and Gramnegative bacterium in comparison to standard drugs, penicillin
and streptomycin. The results also divulge more susceptibility
of these compounds for selected Gram positive bacteria viz.
Lactobacillus casei (NCIM-2651); Bacillus cereus (NCIM-
2458) and Staphylococcus aureus (NCIM-2120).
Compounds 4a, 8a, 13b and 17b displayed more potent
activities than streptomycin against L. casei, 12, 14b and 16b
are substantially active, where as 3a, 5a, 7a, 9a, 11b and 18b
are moderately active and rest of the compounds were found
weakly active for the same strain. More potent activities are
also reported against B. cereus by 13b and 17b where as 4a
and 8a exhibited equipotent activity, while rest of the com-
pounds were found moderate to weakly active for the same
in comparison to streptomycin. S. aureus has documented
the most susceptibilities towards synthesized compounds
Table 3 Molinspiration calculations (Series A & B).
Sr. no. miLogP TPSA natoms MW nON nOHNH nrotb Volume nViolations MOA*
1a 3.82 89.62 21 339.21 6 3 3 251.71 0 GPCRL: 0.11, ICM: 1.41, KI: 0.10, NCL: 2.03
2a 4.07 101.65 24 359.85 7 4 6 295.11 0 GPCRL: 0.22, ICM: 1.20, KI: 0.09, NCL: 1.48
3a 4.86 101.65 25 375.89 7 4 7 317.54 0 GPCRL: 0.06, ICM: 1.02, KI 0.05, NCL: 1.20
4a 5.14 101.65 27 395.88 7 4 5 321.99 1 GPCRL: 0.12, ICM: 0.87, KI 0.08, NCL: 1.45
5a 4.08 114.79 27 399.87 8 4 6 320.35 0 GPCRL: 0.40, ICM: 1.07, KI: 0.09, NCL: 2.09
6a 4.94 89.62 24 376.90 6 3 6 300.84 0 GPCRL: 0.62, ICM: 1.48, KI: 0.65, NCL: 1.79
7a 5.74 89.62 25 392.94 6 3 7 323.27 1 GPCRL: 0.39, ICM: 1.22, KI: 0.68, NCL: 1.51
8a 5.28 89.62 27 412.93 6 3 5 327.71 1 GPCRL: 0.45, ICM: 1.19, KI: 0.14, NCL: 1.77
9a 5.15 102.76 27 416.92 7 3 6 326.08 1 GPCRL: 0.55, ICM: 1.34, KI: 0.44, NCL: 2.25
10b 4.43 89.62 22 373.66 6 3 3 265.25 0 GPCRL: 0.10, ICM: 1.33, KI: 0.10, NCL: 1.91
11b 4.67 101.65 25 394.29 7 4 6 308.65 0 GPCRL: 0.21, ICM: 1.14, KI: 0.10, NCL: 1.41
12b 5.47 101.65 26 410.33 7 4 7 331.08 1 GPCRL: 0.06, ICM: 0.97, KI 0.03, NCL: 1.13
13b 5.75 101.65 28 430.32 7 4 5 335.52 1 GPCRL: 0.12, ICM: 0.82, KI 0.07, NCL: 1.39
14b 4.69 114.79 28 434.31 8 4 6 333.89 0 GPCRL: 0.39, ICM: 1.02, KI: 0.10, NCL: 2.01
15b 5.55 89.62 25 411.34 6 3 6 314.37 1 GPCRL: 0.60, ICM: 1.41, KI: 0.64, NCL: 1.70
16b 6.34 89.62 26 427.39 6 3 7 336.80 1 GPCRL: 0.37, ICM: 1.16, KI: 0.67, NCL: 1.44
17b 5.88 89.62 28 447.38 6 3 5 341.25 1 GPCRL: 0.43, ICM: 1.13, KI: 0.15, NCL: 1.70
18b 5.76 102.76 28 451.36 7 3 6 339.62 1 GPCRL: 0.53, ICM: 1.28, KI: 0.43, NCL: 2.15
Penicillin G 1.82 86.71 23 320.37 6 2 4 287.55 0 GPCRL: 0.56, ICM: 0.41, KI: 0.74, NCL: 0.45
r2 value# 0.17 0.07 0.57 0.27 0.22 0.10 0.07 0.51
* G-protein coupled receptor ligand: GPCRL; Ion channel modulator: ICM; Kinase inhibitor: KI; Nuclear receptor Ligand: NCL.
# Average MIC.
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displayed equipotent activity to Penicillin. S. typhimurium
achieved the moderate to weak activity by these compounds,
excluding 4a, 8a, 13b and 17b. Compounds 8a and 13b dis-
played potent activities than penicillin for Gram negative
E. coli, 4a and 17b were found equipotent where as rest of
the compounds were found weakly active for the same strains.
Along with promising activities, the results also unveil that K.
aerogenes (MIC = 25–200 lg/ml) has shown no activity to-
wards synthesized compounds.
Analogues were synthesized in which chlorine of 1a was re-
placed by various aliphatic and aromatic (heterocyclic) frag-
ments like allyl, butyl, phenyl and methyl furanyl bearing
different amine (–NH–) and mercapto (–S–) as a linker bridge.
From series A, 4a and 8a was found to be the most active ana-
logue. The phenyl fragment appears to be an indispensable
trait for optimal activity and the more prominent activity
was also observed for gram negative bacteria when amine
(4a) was replaced by mercapto bridge (8a) and it was found
more potent to the standard drug penicillin for some gram neg-
ative bacteria such as S. typhimurium and E. coli. The 4a and
8a were found equipotent to penicillin and more potent than
streptomycin for gram positive bacteria S. aureus.
Similarly analogues of compound 10b (Series B) having di-
chloro phenyl thiazole portion were synthesized by replacing
chlorine of s-triazine by various aliphatic and aromatic (het-
erocyclic) groups by incorporating amine (–NH–) and mer-
capto (–S–) as a linker bridge. Among them the most active
triazine were 13b and 17b, again the phenyl fragment was char-
acterized as vital facet for antibacterial activity and the more
pronounced activity was also observed for gram negative bac-
teria when amine (13b) was replaced by mercapto bridge (17b)
and it was found equipotent to the standard drug penicillin for
E. coli. Besides that, presence of intact chlorine (10b) does not
have any marked inﬂuence on antibacterial activity. Further,
activity ﬂourishes upon replacement of chlorine of analogue1 by other aliphatic and aromatic including heterocyclic moie-
ties. But, slight increase in activity was observed in furan frag-
ment connected by amine bridge rather than their
corresponding mercapto bridge in a comparison test. On com-
paring the MICs of allyl fragments (11b and 15b), presence of
amine bridge leads to increase in activity (11b) with their cor-
responding mercapto bridge (15b) but could not translate into
signiﬁcant antibacterial activity.
It is quite ambiguous from the virtual studies, that title
compounds show plausible mode of antibacterial action by nu-
clear receptor ligand binding domain (Table 3), which trigger
key steps during development, and induce or inhibit cellular
proliferation, differentiation and death. It is apparent with
accordance of natoms (r2 = 0.57) and volume (r2 = 0.51)
maximize the number of hydrophobic contacts, thus contribut-
ing to the stability of the complex and the selectivity of the
pocket for the cognate ligand. Whilst the violation of Lipin-
ski’s rule for lipophilicity showed no selectivity, as the corre-
sponding phenyl groups showed maximum efﬁcacy indicating
the applicability of Ghose rule for these set of compounds.
5. Conclusion
As concluding remark, we can see that comparatively strong
activity is demonstrated by di-chloro phenylthiazolyl-s-triazine
than monochloro phenylthiazolyl-s-triazine derivatives. Intro-
duction of more electronic withdrawing groups like chlorine to
phenylthiazole may improve the antibacterial activities in case
of some amino derivatives. Further, by changing the substitu-
tion pattern with allyl group from butyl improves the antibac-
terial activity in a signiﬁcant manner, which in turn also
ﬂourishes by methyl furanyl group but the strongest activity
is demonstrated by phenyl groups, among them compounds
4a, 8a, 13b and 17b were found more potent than streptomycin
for some gram positive microorganism. Ultimately, it will rec-
ommend that presence of –S– linker bridge between s-triazine
40 P. Gahtori et al.and phenylthiazole lessen the antibacterial activity than their
amine bridge equivalents.
6. Experimental
All chemicals were of analytical grade and used without fur-
ther puriﬁcation. Melting points were determined on a Veego,
Model No. MPI open capillary melting point apparatus and
were uncorrected. The completion of reaction was checked
by thin layer chromatography (TLC) using silica gel-GF254
(0.5 mm thickness, Benzene, Ethyl acetate and 0.1 M alcoholic
KOH solvent system) and spots were visualized under ultravi-
olet (UV) radiation. FTIR (in KBr) were recorded on Perkin
Elmer-Spectrum RX-I spectrophotometer. 1H NMR spectra
were recorded on Bruker Avance II 400 NMR Spectrometer
in DMSO-d6 using TMS as internal standard (chemical shift
in d, ppm). Elemental analysis was carried out on a Vario
EL III elemental analyzer and was within ±0.4% of the theo-
retical values.
7. General procedure for synthesis of mono-chloro
phenylthiazolyl-s-triazine derivatives (1a–9a)
The synthesis of targeted compounds 1a–9a is shown in
Scheme 1. The 2-Amino-4,6-dichloro-1,3,5-triazine (1) was
prepared according to published procedure (Thruston et al.,
1951), under ammonia stream at constantly maintained tem-
perature 0–5 C with diethyl cellosolve, ﬁltered under vacuum
and recrystallized from water. The resulting mass 1 (1 mol) and
synthesized (40-chlorophenyl)thiazolyl-2-amine (1 mol) mix-
ture were heated and NaHCO3 (1 mol) was added slowly at
room temperature 40–45 C under aq. Dioxane with constant
stirring for 10 mins, ﬁltered immediately under vacuum to
furnish (40-Chlorophenyl)thiazolyl-s-triazine (1a). The various
substituted amines (0.1 mmol) and substituted thiols
(0.1 mmol) were added to 1a in 100 ml dioxane under nitrogen
atmosphere in NaHCO3 (0.1 mmol) at 120 C for 6 h. The
product was ﬁltered, washed with water, and puriﬁed by ﬂash
column chromatography (Silica gel mesh size 100–200) using
methanol/ethyl acetate (1:20 v/v) as eluent to afford pure
mono-chloro phenylthiazolyl-s-triazine derivatives 2a–9a.
7.1. 6-Chloro-N2-(4-(4-chlorophenyl)thiazol-2-yl)-1,3,5-
triazine-2,4-diamine (1a)
Physical state: Brownish yellow solid; %Yield: 91.65; mp: 158–
160 C; Rf (Silica gel GF254): 0.2758 (Benzene: Ethyl acetate:
0.1 M alco. KOH 2:3:5); FTIR (KBr, cm1): 1353 (C–N), 1694
(C‚N), 1665 (C‚C), 1473 (C‚C Ar bending), 3323 & 3456
(NH2), 3310 (NH), 3030 (Ar–C–H);
1H NMR (400 mHz, d
ppm): 4.33 (s, 2H, NH2), 4.82 (s, 1H, NH), 6.50 (s, 1H, 1-
CH thiazole), 7.05 (d, 2H, Ar–H), 7.25 (d, 2H, Ar–H); Anal.
Calcd for C12H8Cl2N6S: C-42.49, H-2.38, N-24.78, Found C-
42.62, H-2.37, N-24.47.
7.2. N2-allyl-N4-(4-(4-chlorophenyl)thiazol-2-yl)-1,3,5-
triazine-2,4,6-triamine (2a)
Physical state: Light brown solid; %Yield: 84.22; mp: 94–
96 C; Rf (Silica gel GF254): 0. 8012 (Benzene: Ethyl acetate:
0.1 M alco. KOH 3:3:4); FTIR (KBr, cm1): 1350 (C–N),1688 (C‚N), 1669 (C‚C cis/vinyl), 1474 (C‚C Ar bending),
3324, 3458 (NH2), 3314 (NH), 3037 (Ar–C–H);
1H NMR
(400 mHz, d ppm): 3.72 (t, 2H, CH2), 4.12 (s, 2H, NH2),
4.45 (m, 1H, NH), 4.68 (s, 1H, NH), 5.14 (d, 2H, J= 9,
CH2‚C ethylene), 5.79–5.93 (m, 1H, CH‚C ethylene), 6.38
(s, 1H, 1-CH thiazole), 7.02 (d, 2H, Ar–H), 7.20 (d, 2H, Ar–
H); Anal. Calcd for C15H14ClN7S: C-50.07, H-3.92, N-27.25
Found C-49.98, H-3.97, N-27.10.
7.3. N2-butyl-N4-(4-(4-chlorophenyl)thiazol-2-yl)-1,3,5-
triazine-2,4,6-triamine (3a)
Physical state: Brownish Yellow solid; %Yield: 64.77; mp:
146–148 C; Rf (Silica gel GF254): 0.7867 (Benzene: Ethyl ace-
tate: 0.1 M alco. KOH 3:3:4); FTIR (KBr, cm1): 1103 (Ar–
Cl), 1361 (C–N), 1687 (C‚N), 1475 (C‚C Ar bending),
2880 (CH2 Stretch), 3320, 3454 (NH2), 3317 (N–H), 3023
(Ar–C–H); 1H NMR (400 mHz, d ppm): 1.05 (t, 3H, –CH3),
1.38 (m, 2H, –CH2–), 1.58 (m, 2H, –CH2–), 3.21 (m, 2H, N–
CH2–), 3.52 (s, 2H, NH2), 4.23 (m, 1H, NH), 4.76 (s, 1H,
NH), 6.62 (s, 1H, 1-CH thiazole), 6.92 (d, 2H, Ar–H), 7.11
(d, 2H, Ar–H); Anal. Calcd for C16H18ClN7S: C-51.13, H-
4.83, N-26.08 Found C-51.36, H-4.86, N-26.28.
7.4. N2-(4-(4-chlorophenyl)thiazol-2-yl)-N4-phenyl-1,3,5-
triazine-2,4,6-triamine (4a)
Physical state: Light yellow solid; %Yield: 62.54; mp: 112–
114 C; Rf (Silica gel GF254): 0.7142 (Benzene: Ethyl acetate:
0.1 M KOH 3:3:4); FTIR (KBr, cm1): 1033 (Ar–Cl), 1252 (C–
N), 1639 (C‚N), 1445 (C‚C, Ar bending), 3230, 3410 (NH2,
two peaks), 3324 (N–H broad peak), 3041(Ar–C–H); 1H NMR
(400 mHz, d ppm) 4.22 (s, 2H, NH2), 4.58 (s, 1H, NH), 4.81 (s,
1H, NH), 6.42 (s, 1H, 1-CH thiazole), 6.89 (d, 2H, Ar–H), 7.04
(d, 2H, Ar–H), 7.22 (d, 1H, Ar–H), 7.39 (t, 2H, Ar–H), 7.52 (d,
2H, Ar–H); Anal. Calcd for C18H14ClN7S: C-54.61, H-3.56, N-
24.77 Found C-54.12, H-3.78, N-24.79.
7.5. N2-(4-(4-chlorophenyl)thiazol-2-yl)-N4-(furan-2-
ylmethyl)-1,3,5-triazine-2,4,6-triamine (5a)
Physical state: Whitish brown solid; %Yield: 68.25; mp: 49–
51 C; Rf (Silica gel GF254): 0.8216 (Benzene: Ethyl acetate:
0.1 M KOH 3:3:4); FTIR (KBr, cm1) 1063 (Ar–Cl), 1352
(C–N), 1683 (C‚N), 1470 (C‚C Ar bending), 3322, 3456
(NH2), 3312 (NH), 3032 (Ar–C–H);
1H NMR (400 mHz, d
ppm): 3.32 (s, 2H, –CH2), 4.27 (s, 2H, NH2), 4.87 (s, 1H,
NH), 4.94 (s, 1H, NH), 5.88 (d, 1H, 30CH-furan), 6.18 (t,
1H, 40CH-furan), 6.44 (s, 1H, 1-CH thiazole), 6.76 (d, 1H,
50CH-furan), 7.04 (d, 2H, Ar–H), 7.23 (d, 2H, Ar–H); Anal.
Calcd for C17H13ClN6OS2: C-48.98, H-3.14, N-20.16 Found
C-48.50, H-3.33, N-20.49.7.6. 6-(Allylthio)-N2-(4-(4-chlorophenyl)thiazol-2-yl)-1,3,5-
triazine-2,4-diamine (6a)
Physical state: Dark Brown solid; %Yield: 52.36; mp: 91–
93 C; Rf (Silica gel GF254): 0.7661 (Benzene: Ethyl acetate:
0.1 M KOH 3:3:4); FTIR(KBr, cm1): 1053 (Ar–Cl), 1252
(C–N), 1639 (C‚N), 1445 (C‚C Ar bending), 3230, 3410
Synthesis, SAR and antibacterial activity of hybrid chloro, dichloro-phenylthiazolyl-s-triazines 41(NH2, two peaks), 3041 (Ar–C–H);
1H NMR (400 mHz, d
ppm): 3.68 (t, 2H, CH2), 4.10 (d,2H,NH2), 4.36 (s, 1H, NH),
5.10 (d, 2H, J= 9, CH2‚C ethylene), 5.68 (m, 1H, CH‚CH2
ethylene), 6.34 (s, 1H, 1-CH thiazole), 6.99 (d, 2H, Ar–H), 7.07
(d, 2H, Ar–H); Anal. Calcd for C15H13ClN6S2: C-47.80, H-
3.48, N-22.30 Found C-47.62, H-3.57, N-22.67.
7.7. 6-(Butylthio)-N2-(4-(4-chlorophenyl)thiazol-2-yl)-1,3,5-
triazine-2,4-diamine (7a)
Physical state: Light brown liquid; %Yield: 75.24; mp: 10–
12 C; Rf (Silica gel GF254): 0.7602 (Benzene: Ethyl acetate:
0.1 M KOH 3:3:4); FTIR(KBr, cm1): 1052 (Ar–Cl), 1246
(C–N), 1628 (C‚N), 1435 (C‚C Ar bending), 2850 (CH2
stretching) 3250, 3453(NH2, two peaks), 3022 (Ar–C–H);
1H
NMR (400 mHz, d ppm) 1.01 (t, 3H, –CH3), 1.30 (m, 2H, –
CH2–), 1.39 (m, 2H, –CH2–), 3.12 (m, 2H, N–CH2–), 3.42 (s,
2H, NH2), 6.52 (s, 1H, 1-CH thiazole), 6.87 (d, 2H, Ar–H),
7.08 (d, 2H, Ar–H); Anal. Calcd for C16H17ClN6S2: C-48.91,
H-4.36, N-21.39 Found C-48.32, H-4.98, N-21.36.
7.8. N2-(4-(4-chlorophenyl)thiazol-2-yl)-6-(phenylthio)-1,3,5-
triazine-2,4-diamine (8a)
Physical state: Yellow solid; %Yield: 74.67; mp: 135–137 C;
Rf (Silica gel GF254): 0. 7576 (Benzene: Ethyl acetate: 0.1 M
KOH 3:3:4); FTIR (KBr, cm1): 1039 (Ar–Cl), 1242 (C–N),
1654 (C‚N), 1437 (C‚C Ar bending), 3300, 3457 (NH2,
two peaks), 3064 (Ar–C–H); 1H NMR (400 mHz, d ppm):
4.19 (s, 2H, NH2), 4.90 (s, 1H, NH), 6.35 (s, 1H, 1-CH thia-
zole), 7.02(d, 2H, Ar–H), 7.18 (d, 2H, Ar–H), 7.22 (t, 1H,
Ar–H), 7.27 (d, 2H, Ar–H), 7.32 (d, 2H, Ar–H); Anal. Calcd
for C16H17ClN6S2: C-48.91, H-4.36, N-21.39 Found C-48.32,
H-3.98, N-22.06.
7.9. N2-(4-(4-chlorophenyl)thiazol-2-yl)-6-(furan-2-
ylmethylthio)-1,3,5-triazine-2,4-diamine (9a)
Physical state: Dark brown solid; %Yield: 58.88; mp: 87–
89 C; Rf (Silica gel GF254): 0.8142 (Benzene: Ethyl acetate:
0.1 M KOH 3:3:4); FTIR (KBr, cm1): 1076 (Ar–Cl), 1266
(C–N), 1612 (C‚N), 1482 (C‚C Ar bending), 3289, 3458
(NH2, two peaks), 3056 (Ar–C–H);
1H NMR (400 mHz, d
ppm): 3.24 (s, 2H, –CH2), 3.31 (s, 2H, NH2), 4.47 (s, 1H,
NH), 5.76 (d, 1H, 30CH-furan), 6.09 (t, 1H, 40CH-furan),
6.22 (s, 1H, 1-CH thiazole), 6.65 (d, 1H, 50CH-Furan), 6.84
(d, 2H, Ar–H), 6.88 (d, 2H, Ar–H); Anal. Calcd for
C17H14ClN7OS: C-51.06, H-3.53, N-24.52 Found C-50.82, H-
3.67, N-22.78
8. General procedure for synthesis of di-chloro phenylthiazolyl-s-
triazine derivatives (10b–18b)
The previously prepared 1 (1 mol) was heated with synthesized
(30,40-Dichlorophenyl)thiazolyl-2-amine (1 mol) and NaH-
CO3(1 mol) mixture at constant temperature 40–45 C with
uniform stirring for 10 mins, ﬁltered immediately under vac-
uum to yield (30,40-dichlorophenyl)thiazolyl-s-triazine (10b).
The various substituted amines (0.1 mmol) and substituted thi-
ols (0.1 mmol) were added to 10b into 100 ml dioxane under
nitrogen atmosphere in NaHCO3 (0.1 mmol) at 120 C for6 h. The product was ﬁltered, washed with water, and puriﬁed
by ﬂash column chromatography(Silica gel mesh size 100–200)
using methanol/ethyl acetate (1:20 v/v) as eluent to furnish
pure di-chloro phenylthiazolyl-s-triazine derivatives 11b–18b.
8.1. 6-Chloro-N2-(4-(3,4-dichlorophenyl)thiazol-2-yl)-1,3,5-
triazine-2,4-diamine (10b)
Physical state: Whitish Yellow solid; %Yield: 73.33; mp: 158–
160 C; Rf (Silica gel GF254): 0.5714 (Benzene: Ethyl acetate:
0.1 M alco. KOH 2:3:5); FTIR (KBr, cm1): 1043 (Ar–Cl),
1271 (C–N), 1678 (C‚N), 1455 (C‚C Ar bending), 3289,
3499 (NH2, two peaks), 3326 (N–H broad peak), 3098 (Ar–
C–H); 1H NMR (400 mHz, d ppm): 4.48 (s, 2H, NH2), 4.98
(s, 1H, NH), 6.67 (s, 1H, 1-CH thiazole), 7.29 (d, 1H, Ar–
H), 7.49 (d, 1H, Ar–H), 7.55 (s, 1H, Ar–H); Anal. Calcd for
C12H7Cl3N6S: C-38.57, H-1.89, N-22.49 Found C-38.48, H-
1.93, N-22.11.
8.2. N2-allyl-N4-(4-(3,4-dichlorophenyl)thiazol-2-yl)-1,3,5-
triazine-2,4,6-triamine (11b)
Physical state: Brownish yellow solid; %Yield: 64.17; mp: 54–
56 C; Rf (Silica gel GF254): 0.7517 (Benzene: Ethyl acetate:
0.1 M alco. KOH 3:3:4); FTIR (KBr, cm1) 1103 (Ar–Cl),
1252 (C–N), 1654 (C‚N), 1679 (C‚C), 1492 (C‚C Ar bend-
ing), 3279, 3477 (NH2, two peaks), 3198 (N–H broad peak),
3024 (Ar–C–H); 1H NMR (400 mHz, d ppm): 3.86 (t, 2H,
N–CH2), 5.27 (d, 2H, CH2‚CH2), 5.85 (m, 1H, C–
HC‚CH2), 4.31 (s, 2H, NH2), 4.62 (m, 1H,NH), 6.60 (s,
1H, 1-CH thiazole), 7.26 (d, 1H, 3-ArH), 7.31 (d, 1H, 2-Ar–
H), 7.49 (s, 1H, 5-Ar–H); Anal. Calcd for C15H13Cl2N7S: C-
45.69, H-3.32, N-24.87 Found C-45.48, H-3.30, N-24.95.
8.3. N2-butyl-N4-(4-(3,4-dichlorophenyl)thiazol-2-yl)-1,3,5-
triazine-2,4,6-triamine (12b)
Physical state: Whitish brown solid; %Yield: 59.34; mp: 122–
124 C; Rf (Silica gel GF254): 0.7342 (Benzene: Ethyl acetate:
0.1 M alco. KOH 3:3:4); FTIR (KBr, mmax cm
1), 1053 (Ar–
Cl), 1152 (C–N), 1645 (C‚N), 1475 (C‚C Ar bending),
3239& 3409 (NH2, two peaks), 3201 (N–H broad peak), 2856
(CH2 stretching), 3041 (Ar–C–H);
1H NMR (400 mHz, d
ppm): 1.27 (t, 3H, CH3), 1.53 (m, 2H, CH2), 1.80 (m, 2H,
CH2), 3.49 (m, 2H, N–CH2), 3.77 (s, 2H, NH2), 4.78 (m, 1H,
NH), 6.53 (s, 1H, 1-CH thiazole), 7.31 (d, 1H, 3-Ar–H), 7.51
(d, 1H, 2-Ar–H), 7.47 (s, 1H, 5-Ar–H); Anal. Calcd for
C16H17Cl2N7S: C-46.83, H-4.18, N-23.89 Found C-46.48, H-
4.22, N-23.88.
8.4. N2-(4-(3,4-dichlorophenyl)thiazol-2-yl)-N4-phenyl-1,3,5-
triazine-2,4,6-triamine (13b)
Physical state: Light brown solid; %Yield: 70.12; mp: 113–
115 C; Rf (Silica gel GF254): 0.6613 (Benzene: Ethyl acetate:
0.1 M alco. KOH 3:3:4); FTIR (KBr, cm1) 1079 (Ar–Cl),
1264 (C–N), 1683 (C‚N), 1412 (C‚C Ar bending), 3340,
3480 (NH2, two peaks), 3324 (N–H broad peak), 3086 (Ar–
C–H); 1H NMR (400 mHz, d ppm) 4.34 (s, 2H, NH2), 4.64
(s, 1H, NH), 5.01 (s,1H,NH), 6.54 (s,1H,1-CH Thiazole),
7.29 (d,2H,Ar0H), 7.31 (t,1H,Ar0H), 7.44 (t,2H,Ar0H), 7.61
42 P. Gahtori et al.(d, 1H, 3-Ar–H), 7.76 (d, 1H, 2-Ar–H), 7.89 (s, 1H,5-Ar–H);
Anal. Calcd for C18H13Cl2N7S: C-50.24, H-3.05, N-22.78
Found C-50.02, H-3.06, N-22.75.
8.5. N2-(4-(3,4-dichlorophenyl)thiazol-2-yl)-N4-(furan-2-
ylmethyl)-1,3,5-triazine-2,4,6-triamine (14b)
Physical state: Yellow solid; %Yield: 71.27; mp: 107–109 C;
Rf (Silica gel GF254): 0.6724 (Benzene: Ethyl acetate: 0.1 M
alco. KOH 3:3:4); FTIR (KBr, cm1) 1049 (Ar–Cl), 1259
(C–N), 1629 (C‚N), 1444 (C‚C Ar bending), 3357, 3468
(NH2, two peaks), 3304 (N–H broad peak), 3101 (Ar–C–H);
1H NMR (400 mHz, d ppm): 4.44 (s, 2H, NH2), 4.65 (m,
1H, NH), 4.82 (s, 1H, NH), 6.12 (d, 1H, 30CH-furan), 6.24
(m, 1H, 40CH-furan), 6.46 (s, 1H, 1-CH thiazole), 7.28 (d,
1H, 50CH-furan), 7.30 (d, 1H, 3-Ar–H), 7.37 (d, 1H, 2-Ar–
H), 7.46 (s, 1H, 5-Ar–H); Anal. Calcd for C17H13Cl2N7OS:
C-47.01, H-3.02, N-22.58 Found C-46.89, H-2.98, N-22.50.
8.6. 6-(Allylthio)-N2-(4-(3,4-dichlorophenyl)thiazol-2-yl)-
1,3,5-triazine-2,4-diamine (15b)
Physical state: Yellowish black solid; %Yield: 46.69; mp: 92–
94 C; Rf (Silica gel GF254): 0.7196 (Benzene: Ethyl acetate:
0.1 M alco. KOH 3:3:4); FTIR (KBr, cm1): 1054 (Ar–Cl),
1256 (C–N), 1669 (C‚N), 1668 (C‚C), 1476 (C‚C Ar bend-
ing), 3356, 3421 (NH2, two peaks), 3307 (N–H broad peak),
3123 (Ar–C–H); 1H NMR (400 mHz, d ppm): 3.60 (d, 2H,
S–CH2), 5.03 (d, 2H, C‚CH2), 5.96 (m, 1H, HC‚C), 4.25–
4.29 (m, 2H, NH2), 4.46 (m, 1H, NH), 6.62 (s, 1H, 1-CH thi-
azole), 7.24 (d, 1H, 3-Ar–H), 7.26 (d, 1H, 2-Ar–H), 7.44 (s, 1H,
5-Ar–H); Anal. Calcd for C15H12Cl2N6S2:C-43.80, H-2.94, N-
20.43 Found C-43.52, H-2.80, N-20.45.
8.7. 6-(Butylthio)-N2-(4-(3,4-dichlorophenyl)thiazol-2-yl)-
1,3,5-triazine-2,4-diamine (16b)
Physical state: Yellowish brown solid; %Yield: 82.34; mp: 76–
78 C; Rf (Silica gel GF254): 0.7098 (Benzene: Ethyl acetate:
0.1 M alco. KOH 3:3:4); FTIR (KBr, cm1): 1045 (Ar–Cl),
1267 (C–N), 1654 (C‚N), 1429 (C‚C Ar bending), 3367,
3406 (NH2, two peaks), 3310 (N–H broad peak), 3066 (Ar–
C–H); 1H NMR (400 mHz, d ppm): 0.94 (t, 3H, CH3), 1.26
(m, 2H, CH2), 1.32 (m, 2H, CH2), 2.94 (m, 2H, S–CH2), 4.26
(s, 2H, NH2), 4.65 (s, 1H, NH), 6.44 (s, 1H, 1-CH thiazole),
7.22 (d, 1H, 3-Ar–H), 7.30 (d, 1H, 2-Ar–H), 7.41 (s, 1H, 5-
Ar–H); Anal. Calcd for C16H16Cl2N6S2: C-44.97, H-3.77, N-
19.66 Found C-43.88, H-3.50, N-19.83.
8.8. N2-(4-(3,4-dichlorophenyl)thiazol-2-yl)-6-(phenylthio)-
1,3,5-triazine-2,4-diamine (17b)
Physical state: Brownish yellow solid; %Yield: 65.89; mp: 92–
94 C; Rf (Silica gel GF254): 0.6984 (Benzene: Ethyl acetate:
0.1 M alco. KOH 3:3:4); FTIR (KBr, cm1) 1094 (Ar–Cl),
1242 (C–N), 1672 (C‚N), 1445 (C‚C Ar bending), 3320,
3411 (NH2, two peaks), 3301 (N–H broad peak), 3083 (Ar–
C–H); 1H NMR (400 mHz, d ppm): 4.25 (s, 2H, qaNH2),
4.44 (s, 1H, NH), 6.55 (s, 1H, 1-CH thiazole), 7.10 (m, 2H,
Ar0–H), 7.08 (m, 1H, Ar0–H), 7.21 (m, 2H, Ar0–H), 7.33 (d,
1H, 3-Ar–H), 7.41 (d, 1H, 2-Ar–H), 7.47 (s, 1H, 5-Ar–H);Anal. Calcd for C18H12Cl2N6S2: C-48.33, H-2.70, N-18.79
Found C-47.98, H-2.91, N-18.56.
8.9. N2-(4-(3,4-dichlorophenyl)thiazol-2-yl)-6-(furan-2-
ylmethylthio)-1,3,5-triazine-2,4-diamine (18b)
Physical state: Greenish brown semisolid; %Yield: 55.88; mp:
55–57 C; Rf (Silica gel GF254): 0.7684 (Benzene: Ethyl ace-
tate: 0.1 M alco. KOH 3:3:4); FTIR (KBr, cm1) 1076 (Ar–
Cl), 1248 (C–N), 1669 (C‚N), 1447 (C‚C Ar bending),
3330, 3479 (NH2, two peaks), 3310 (N–H broad peak), 3057
(Ar–C–H); 1H NMR (400 mHz, d ppm): 4.29 (m, 2H, N–
CH2), 4.10 (s, 2H, NH2), 4.38 (m, 2H, NH), 6.08 (d, 1H,
30CH-furan), 6.24 (m, 1H, 40CH-furan), 6.41 (s, 1H, 1-CH thi-
azole), 7.28 (d, 1H, 50CH-furan), 7.34 (d, 1H, 3-Ar–H), 7.40 (d,
1H, 2-Ar–H), 7.48 (s, 1H, 5-Ar–H); Anal. Calcd for
C17H13Cl2N7OS: C-47.01, H-3.02, N-22.58 Found C-46.89,
H-3.47, N-22.50.
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